It’s Wednesday and that means it’s time again to pay special thanks to our premium partner – Biovays.

Biovays is a young and flourishing biotechnology CRO that boasts unique savoir-faire in the expression, localisation and quantification of biomarkers. The company’s aim is to provide flexible, fully customized services within the constraints of the project environment – meeting client demands for accuracy, timeliness and cutting-edge research.

Harnessing state-of-the-art technology and expertise in molecular imaging, Biovays offers powerful analytical tools to several industries – opening up new possibilities for the screening of drug candidates.

Via tailor-made protocols and a range of highly specialised models, Biovays helps clients leverage benefits and focus on their core business. From target discovery through to FDA approval, their innovative quantitative biomarker analysis streamlines drug development and boosts drug approval success rates.

For more information on Biovays, visit their website at biovays.com.

Image from Biovays

Related Posts